AXSM (Axsome Therapeutics, Inc.) Kompaniyaning sof aktivlari

Ommaviy kompaniya Axsome Therapeutics, Inc. (AXSM) logotipi

Axsome Therapeutics (AXSM) shakllangan tijorat platformalarini sotib olish va tibbiyot markazlari bilan hamkorlik qilish orqali neyrobiologiya sohasidagi ta'sirini kengaytirmoqda. Shu bilan birga, kompaniya migren va depressiyani davolash vositalarining tarqatilishini kengaytirmoqda, bu yo'nalishda talab 0.08 darajasiga yetmoqda. Quyidagi kundalik narxlar grafigi aktivning bozor tendentsiyalarini aks ettiradi. Biroq, geosiyosiy keskinliklar va sanksiyalar komponentlarning importi hamda noyob dori vositalarining ayrim hududlarga eksport qilinishiga to'sqinlik qilishi mumkin.

AXSM Axsome Therapeutics, Inc. Balans kapitallashuvi (04.07.2022 - 27.10.2026)

Axsome Therapeutics, Inc. (AXSM) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Birja grafigi Axsome Corp|AXSM - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi Axsome|AXSM - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Axsome Therapeutics|AXSM - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti axsome.com|AXSM - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Axsome Therapeutics|AXSM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Axsome|AXSM - Kompaniya qarzlari|Balans qiymatiga qarzlar Axsome
Kompaniyaning jamlanma tahlili:AXSM - Axsome Corp
Axsome yetakchi tovari

Balans qiymati aktivlarning majburiyatlar ayirib tashlangan sof qiymatini aks ettiradi va bozor tebranishlaridan qat’i nazar, biznesning real qiymatini belgilovchi ob’yektiv buxgalteriya ankor vazifasini o‘taydi. Axsome Therapeutics (AXSM) uchun balans qiymatining joriy darajasi intellektual mulkning kapitalizatsiyasini va Auvelity dan kelayotgan pul oqimlarining o‘sishini tasdiqlaydi, bu esa barqaror daromadga erishish uchun mustahkam poydevor yaratilayotganidan dalolat beradi.

Axsome Therapeutics raqobatchilari tahlili

BIIB: Biznesning balans bahosi|NBIX (Neurocrine Biosciences) - Kompaniyaning balans qiymati|RGC (regencellbioscience.com) - Kompaniyaning sof aktivlari|Kompaniyaning balans qiymati ACADIA Pharmaceuticals Inc. (ACAD)|Buxgalteriya kapitallashuvi Xenon Pharmaceuticals Inc.|Viking Pharma - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Supernus Corp SUPN|Kompaniyaning sof aktivlari CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati AMLX|Trevi Corp (TRVI) - Kompaniyaning xususiy kapitali|PRAX (Praxis Precision Medicines) - Balans kapitallashuvi|Balans kapitallashuvi anavex.com (AVXL)|Kompaniyaning sof aktivlari CeriBell CBLL|Buxgalteriya kapitallashuvi PRTA (Prothena Corporation)|Kompaniyaning balans qiymati ALEC|Annexon Biosciences Inc. - Biznesning balans bahosi|OMER (Omeros Corp.) - Kompaniyaning balans qiymati|NGNE: Kompaniyaning xususiy kapitali|ACIU (AC Immune SA) - Kompaniyaning balans qiymati|Voyager Therapeutics Inc (VYGR) - Kompaniyaning sof aktivlari|Balans kapitallashuvi NMRA (Neumora Therapeutics Inc)|Kompaniyaning xususiy kapitali Scilex Holding Company, Inc. (SCLX)|Tevogen Bio Holdings (TVGN) - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati alphacognition.com ACOG|Kompaniyaning sof aktivlari Cognition Therapeutics (CGTX)|Jami sof aktivlar Inhibikase Therapeutics Inc IKT|Balans kapitallashuvi Cassava (SAVA)|ASRT - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi COYA|VTGN (Vistagen) - Kompaniyaning xususiy kapitali|OVID - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati Acumen Pharmaceuticals Inc.|Balans kapitallashuvi CRVO|Balans kapitallashuvi ATHE (alteritytherapeutics.com)|Clene (CLNN) - Kompaniyaning balans qiymati|Sof aktivlar qiymati PepGen Inc PEPG|JUNS (Jupiter Neurosciences Inc) - Balans kapitallashuvi|Relmada Therapeutics Inc (RLMD) - Kompaniyaning xususiy kapitali|ANVS: Kompaniyaning sof aktivlari|Balans kapitallashuvi Grace Therapeutics|Firefly Neuroscience, Inc (AIFF) - Kompaniyaning sof aktivlari|Jami sof aktivlar ANEW Medical, Inc.|NRSN (NeuroSense Therapeutics) - Balans kapitallashuvi|Biznesning balans bahosi Reviva Pharmaceuticals Holdings Inc. (RVPH)|MetaVia - Balans kapitallashuvi|NeurAxis Inc - Kompaniyaning sof aktivlari|Kompaniyaning balans qiymati HSDT (Helius Medical Technologies Inc.)|PASG - Biznesning balans bahosi|NEUP: Balans kapitallashuvi|Balans kapitallashuvi Minerva Neurosciences Inc|Kompaniyaning sof aktivlari Athira (ATHA)|Buxgalteriya kapitallashuvi ADXN|ALZN (Alzamend Neuro, Inc.) - Kompaniyaning balans qiymati|Biznesning balans bahosi CYCN (cyclerion.com)|Protagenic Therapeutics, Inc. - Kompaniyaning balans qiymati|Pasithea Therapeutics Corp - Kompaniyaning sof aktivlari|Cortigent Medical (CRGT) - Kompaniyaning balans qiymati|ATXI - Buxgalteriya kapitallashuvi|Balans kapitallashuvi BCLI|Kompaniyaning xususiy kapitali caratherapeutics.com|CHRO (Chromocell Therapeutics Corp.) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ELYM|Intra-Cellular Therapies (ITCI) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati LBPH (Longboard)|MRNS: Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali nkgenbiotech.com NKGN|NeuroBo Pharmaceuticals, Inc. - Balans kapitallashuvi|Sage Therapeutics Inc. (SAGE) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Neurotrope|TRVN (Trevena Inc) - Buxgalteriya kapitallashuvi|VIGL: Kompaniyaning balans qiymati|Biznesning balans bahosi WENA|Cerevel Therapeutics, Inc. - Kompaniyaning balans qiymati